Coastline Trust Co cut its holdings in shares of Clorox Company (The) (NYSE:CLX) by 2.6% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,945 shares of the company’s stock after selling 130 shares during the quarter. Coastline Trust Co’s holdings in Clorox Company (The) were worth $659,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Jacobi Capital Management LLC increased its holdings in shares of Clorox Company (The) by 0.3% during the first quarter. Jacobi Capital Management LLC now owns 1,282 shares of the company’s stock worth $172,000 after purchasing an additional 4 shares during the period. Bridgeworth LLC increased its holdings in shares of Clorox Company (The) by 0.3% during the first quarter. Bridgeworth LLC now owns 1,869 shares of the company’s stock worth $252,000 after purchasing an additional 5 shares during the period. Valley National Advisers Inc. increased its holdings in shares of Clorox Company (The) by 0.6% during the first quarter. Valley National Advisers Inc. now owns 860 shares of the company’s stock worth $116,000 after purchasing an additional 5 shares during the period. Blue Chip Partners Inc. increased its holdings in shares of Clorox Company (The) by 0.7% during the first quarter. Blue Chip Partners Inc. now owns 906 shares of the company’s stock worth $122,000 after purchasing an additional 6 shares during the period. Finally, Bernzott Capital Advisors increased its holdings in shares of Clorox Company (The) by 0.4% during the second quarter. Bernzott Capital Advisors now owns 1,607 shares of the company’s stock worth $214,000 after purchasing an additional 7 shares during the period. 71.28% of the stock is currently owned by institutional investors.

Shares of Clorox Company (CLX) opened at 135.57 on Wednesday. The company has a market cap of $17.50 billion, a PE ratio of 25.41 and a beta of 0.40. Clorox Company has a 1-year low of $111.24 and a 1-year high of $141.76. The firm’s 50 day moving average is $135.66 and its 200-day moving average is $135.26.

Clorox Company (The) (NYSE:CLX) last issued its quarterly earnings results on Thursday, August 3rd. The company reported $1.53 EPS for the quarter, topping the Zacks’ consensus estimate of $1.49 by $0.04. The firm had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.65 billion. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The business’s revenue for the quarter was up 2.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.30 EPS. Equities analysts expect that Clorox Company will post $5.66 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: This piece was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece on another publication, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this piece can be viewed at https://www.thecerbatgem.com/2017/09/13/coastline-trust-co-sells-130-shares-of-clorox-company-the-clx.html.

CLX has been the topic of several recent research reports. BidaskClub cut shares of Clorox Company (The) from a “hold” rating to a “sell” rating in a report on Wednesday, July 5th. Deutsche Bank AG reissued a “hold” rating and issued a $137.00 price objective (up from $126.00) on shares of Clorox Company (The) in a research note on Saturday, July 22nd. Royal Bank Of Canada reissued a “hold” rating and issued a $115.00 price objective on shares of Clorox Company (The) in a research note on Friday, June 30th. Zacks Investment Research raised shares of Clorox Company (The) from a “hold” rating to a “buy” rating and set a $149.00 price objective on the stock in a research note on Tuesday, July 4th. Finally, Barclays PLC reissued an “equal weight” rating and issued a $136.00 price objective (down from $140.00) on shares of Clorox Company (The) in a research note on Friday, August 4th. Two research analysts have rated the stock with a sell rating, ten have given a hold rating and three have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $129.05.

In other news, EVP James E. Foster sold 9,861 shares of the stock in a transaction on Wednesday, August 23rd. The shares were sold at an average price of $138.51, for a total value of $1,365,847.11. Following the transaction, the executive vice president now owns 22,069 shares of the company’s stock, valued at approximately $3,056,777.19. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, COO Dawn C. Willoughby sold 2,158 shares of the stock in a transaction on Tuesday, August 29th. The stock was sold at an average price of $138.00, for a total transaction of $297,804.00. The disclosure for this sale can be found here. Insiders sold a total of 21,242 shares of company stock worth $2,944,449 in the last three months. Insiders own 0.74% of the company’s stock.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Stock Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related stocks with our FREE daily email newsletter.